CIK 0000926617 · Non-accelerated filer<br>Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330595156
- Phone
- 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-19 | COCOZZA NANCY G Director | Grant or award | +66,218 | 129,506 | ||
| 2020-03-19 | COCOZZA NANCY G Director | Grant or award · Employee Stock Option (Right to Buy) | +115,148 | 115,148 | ||
| 2020-03-19 | COCOZZA NANCY G Director | Grant or award | +66,218 | 129,506 | ||
| 2020-03-19 | COCOZZA NANCY G Director | Grant or award · Employee Stock Option (Right to Buy) | +115,148 | $0.68 | $78K | 115,148 |
| 2020-03-19 | LAFRANCE JAMES T Director | Grant or award | +84,986 | 429,459 | ||
| 2020-03-19 | LAFRANCE JAMES T Director | Grant or award · Employee Stock Option (Right to Buy) | +147,783 | 147,783 | ||
| 2019-11-15 | Beechey Robert Harry Chief Financial Officer | Purchase | +5,000 | $0.71 | $4K | 210,000 |
| 2019-06-28 | Schuler Henri George 10% owner | Purchase | +2,250,000 | $0.80 | $1.8M | 6,047,057 |
| 2019-06-28 | Schuler Henri George 10% owner | Purchase | +2,250,000 | $0.80 | $1.8M | 6,046,957 |
| 2019-06-28 | Schuler Henri George 10% owner | Purchase | +250,000 | $0.80 | $200K | 1,503,177 |
| 2019-06-28 | SCHULER JACK W 10% owner | Purchase | +5,000,000 | $0.80 | $4.0M | 22,378,242 |
| 2019-06-28 | Palmieri Valerie Barber President and CEO | Purchase | +37,500 | $0.80 | $30K | 215,563 |
| 2019-06-03 | SCHREIBER DAVID Director | Sale | −10,000 | $1.10 | $11K | 164,905 |
| 2019-05-17 | Beechey Robert Harry Chief Financial Officer | Purchase | +5,000 | $1.26 | $6K | 205,000 |
| 2019-03-26 | LAFRANCE JAMES T Director | Grant or award | +45,455 | 344,473 | ||
| 2019-03-26 | LAFRANCE JAMES T Director | Grant or award · EMPLOYEE STOCK OPTION (RIGHT TO BUY) | +119,284 | 119,284 | ||
| 2019-03-26 | Burns James S Director | Grant or award | +34,848 | 397,055 | ||
| 2019-03-26 | Burns James S Director | Grant or award · EMPLOYEE STOCK OPTION (RIGHT TO BUY) | +91,451 | 91,451 | ||
| 2019-03-26 | Beechey Robert Harry Chief Financial Officer | Grant or award · EMPLOYEE STOCK OPTION (RIGHT TO BUY) | +150,000 | 150,000 | ||
| 2019-03-26 | Palmieri Valerie Barber President and CEO | Grant or award · EMPLOYEE STOCK OPTION (RIGHT TO BUY) | +450,000 | 450,000 |
Page 14 of 15 · 296 trades